Latest Breaking News On - மாஂட்ஃபர்ட் மோன் - Page 1 : comparemela.com
A smartphone technology to diagnose psychiatric diseases
israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.
Israeli Brain Profiler App Diagnoses Psychosis, Depression and Anxiety
unitedwithisrael.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from unitedwithisrael.org Daily Mail and Mail on Sunday newspapers.
Illustrative image of a robot, Artificial Intelligence (AI); (PhonlamaiPhoto; iStock by Getty Images)
With the coronavirus pandemic pushing many medical appointments online instead of in person, the possibilities of telehealth may now include brain monitoring.
Montfort (Mon4t), an Israel-based medical startup specializing in neurological disorders, announced a new platform last week to help diagnose and treat psychiatric disorders.
Montfort uses smartphone technology and artificial intelligence to conduct remote brain monitoring and FDA-cleared digital neurological tests for patients with Parkinson’s disease, Huntington’s disease and other conditions.
The platform is based on Brain Profiler, a new scientific method that examines mental disorders as brain disturbances, which can be diagnosed in a clinical manner. This new field aims to connect classical psychiatry with computational neuroscience.
Share this article
Share this article
BINYAMINA, Israel, Dec. 16, 2020 /PRNewswire/ Montfort (Mon4t), an innovative medical startup introduces its real-time, remote neurological monitor.
Montfort s FDA-cleared solution leverages smartphone technology, big-data and AI to conduct digital neurological tests for patients with conditions such as Parkinson s disease, Huntington s disease, psychiatric disorders (like schizophrenia), as well as for patients with Post-COVID19 symptoms, some of which are similar to those observed in neurological conditions. About one billion people around the world suffer from neurological and psychiatric disorders. Diagnostics and treatment are based upon short and infrequent clinical visits thus limiting patients quality of care and increasing treatment costs - about 800 Billion USD in the US alone, says